Taho Pharmaceuticals (ROCO:6467) FCF Margin %: -18,401.11% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6467 Taho Pharmaceuticals Ltd ROCO:6467
35 GF Score
Price NT$113.50
! 2 Warning Signs
View Full Analysis

What is Taho Pharmaceuticals FCF Margin %?

Taho Pharmaceuticals ROCO:6467 -4.22% 35 FCF Margin % is -18,401.11% as of Dec. 2025. GuruFocus rates ROCO:6467 with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 961 Drug Manufacturers companies, Taho Pharmaceuticals ranks worse than 97.81% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Taho Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2025 was NT$-116.11 Mil. Taho Pharmaceuticals's Revenue for the six months ended in Dec. 2025 was NT$0.63 Mil. Therefore, Taho Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2025 was -18,401.11%.

As of today, Taho Pharmaceuticals's current FCF Yield % is -3.53%.

The historical rank and industry rank for Taho Pharmaceuticals's FCF Margin % or its related term are showing as below:

ROCO:6467' s FCF Margin % Range Over the Past 10 Years
Min: -10047   Med: -637.08   Max: -244.24
Current: -2497.53

During the past 9 years, the highest FCF Margin % of Taho Pharmaceuticals was -244.24%. The lowest was -10047.00%. And the median was -637.08%.

ROCO:6467's FCF Margin % is ranked worse than
97.81% of 961 companies
in the Drug Manufacturers industry
Industry Median: 2.58 vs ROCO:6467: -2497.53

Taho Pharmaceuticals FCF Margin % Related Terms

Taho Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Taho Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taho Pharmaceuticals FCF Margin % Chart

Taho Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -286.64 -1,116.35 -10,047.00 0.00 -2,497.53

Taho Pharmaceuticals Semi-Annual Data
Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,545.75 0.00 0.00 -1,207.49 -18,401.11

ROCO:6467 vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Taho Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taho Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taho Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Taho Pharmaceuticals's FCF Margin % falls into.


ROCO:6467
35GF Score
Taho Pharmaceuticals Ltd ROCO:6467
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taho Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Taho Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-210.042/8.41
=-2,497.53 %

Taho Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-116.111/0.631
=-18,401.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -18,401.11% mean?
Taho Pharmaceuticals (ROCO:6467) has a FCF Margin % of -18,401.11% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Taho Pharmaceuticals and its competitors. According to the industry distribution chart, Taho Pharmaceuticals ranks #940 out of 961 companies in the Drug Manufacturers industry, placing it in the top 97.8%.
Is Taho Pharmaceuticals' FCF Margin % too high?
Taho Pharmaceuticals' current FCF Margin % is -18,401.11%. Based on the distribution chart, Taho Pharmaceuticals ranks #940 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Taho Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Taho Pharmaceuticals' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Taho Pharmaceuticals ranks #940 out of 961 companies for FCF Margin %. This places Taho Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.58, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Taho Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taho Pharmaceuticals's current FCF Margin % is -18,401.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taho Pharmaceuticals stock overvalued right now?
Taho Pharmaceuticals (ROCO:6467) has a current FCF Margin % of -18,401.11%. The current FCF Margin % is -18,401.11%. Taho Pharmaceuticals' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Taho Pharmaceuticals (ROCO:6467), the current FCF Margin % is -18,401.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Taho Pharmaceuticals Business Description

Address No. 550, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN
Taho Pharmaceuticals Ltd is a Taiwan based company focused on identifying and developing new products that offer therapeutic options to patient populations that may be under served. It offers a transdermal delivery platform that allows the active ingredient to be absorbed by the skin and distributed through the bloodstream. Its transmucosal delivery system delivers the drug as a thin film, an evolution from tablets or capsules. The company is conducting research and development of multiple new drugs using two different drug delivery platform technologies: transdermal and transmucosal.
35GF Score

Get the complete analysis for ROCO:6467

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$113.50
Price